ISSN : 0975-9492
CODEN : IJPSQQ





INTERNATIONAL JOURNAL OF PHARMA SCIENCES AND RESEARCH


Open Access

This website is certified by Health On the Net Foundation. Click to verify.

This site complies with the HONcode standard for trustworthy health information:
verify here.

ABSTRACT

Title : Ethnopharmacological Survey of Euphorbia resinifera in the Atlas Mountains of Azilal- Beni Mellal, Morocco
Authors : Abderrazak EL ALAMI, Abderrazzak FATTAH, Rachida Aboufatima, Abderrahman CHAIT
Keywords : The resin spurge, ethnopharmacology, therapeutic uses, toxicity, Morocco.
Issue Date : Oct 2020
Abstract :
Background: Euphorbia resinifera is an endemic plant to Morocco. It is well known for its innumerable benefits and for its high toxicity. In Morocco and Algeria, the plant is used to treat many diseases such as cancer, rheumatism, cyst and snake bite poisoning. Method: The current work focuses on the study of therapeutic uses of E. resinifera and of honey attributed to this plant in the Atlas Mountains of Azilal-Beni Mellal, Morocco. Information was obtained through interviews with local people in the study area. Then, information on the most abundant secondary metabolites and on biological activities of the study species was collected. Results: Results of interviews showed that 28% of the interviewees used E. resinifera for therapeutic purposes. A total of 91% of the interviewees used honey made from the resin spurge to prevent diseases and 17% of the interviewees used it for therapeutic purposes. Results showed that in this area, E. Resinifera is used mainly to treat different categories of cancers. In addition, preparations of different parts of the plant and its honey were given orally to treat intoxications, envenomation caused by scorpions and snakes, and many genital, respiratory, circulatory, metabolic and infectious diseases. Conclusion: The resin spurge and honey made from it have innumerable benefits because of the diversity of the secondary metabolites which it contains. E. resinifera had great potential as a source of bioactive compounds, which may lead to the development of new drugs for clinical use.
Page(s) : 240-245
ISSN : 0975-9492
Source : Vol. 11, No.10